The FDA is Looking at an Annual COVID-19 Vaccine Like the Flu Jab

Covid-19 Vaccine
Photo by Hakan Nural on Unsplash

For two years, COVID-19 kept us locked in our homes, wearing masks, and keeping our distance. Although borders have re-opened and life is somewhat returning to normal, the deadly virus has not disappeared. 

The Food and Drug Administration (FDA) has now announced its plan on how it hopes to tackle Coronavirus going forward. 

Much like the flu vaccine, it has recommended that people get jabbed against COVID once a year. The ideal time would be as winter begins to approach, as this is when respiratory viruses are most dominant.

With most individuals having already been vaccinated against COVID, only one dose will be necessary to “restore protective immunity for a period of time.” More vulnerable persons, like the elderly, children, and those who are immune-compromised could possibly receive injections every 6 months. 

The composition of the vaccine is likely to target the most common strain at the time, another similarity to the influenza jab. The most recent one is targeted at the original SARS-CoV-2 virus, as well as the omicron version. 

Pfizer and Moderna say they are able to create a vaccine by September if told in late spring which variants to target.